News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Vincent Rajkumar: How this most Notorious Drug on the Planet made an Incredible Comeback
Vincent Rajkumar and Leif Bergsage
May 19, 2025, 13:59

Vincent Rajkumar: How this most Notorious Drug on the Planet made an Incredible Comeback

Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, shared a post on X:

“The fascinating story of Thalidomide: How this most notorious drug on the planet, banned in the 1960s, made an incredible comeback and revolutionized the treatment of myeloma.
I will also highlight one person whose role is not recognized: Without Dr. Leif Bergsage there will be no thalidomide for myeloma.
Read on Med Twitter:
  • The thalidomide story has many takeaways and lessons.
  • It shows drug development from bedside to bench and back to bedside.
  • It shows the power and impact of astute clinicians.
  • It shows the power of investigator courage.
  • The role of serendipity.”
Yelak Biru, President and Chief Executive Officer at International Myeloma Foundation, reshared the post on X, adding:
“While Thalidomode may not be the most prescribed myeloma medicine today (in the US), it ushered a new era of hope, discovery, and progress of myeloma.
Fascinating narrative of how it came to be below by Dr. Vincent Rajkumar.
This resonates with me… and a reminder resilience also applies to progress and not only being a patient and that superheroes come in many forms.
“Dr. Barlogie pictured below is a legend. No one but him would have been willing to try thalidomide of all drugs in myeloma. No one. No.”

Vincent Rajkumar shared insights on the historical significance of thalidomide’s revival in multiple myeloma treatment, emphasizing the roles of clinical courage and serendipity. Yelak Biru echoed the importance of the drug’s legacy, crediting its role in transforming myeloma care and progress.

Vincent Rajkumar: How this most Notorious Drug on the Planet made an Incredible Comeback

More posts featuring Vincent Rajkumar.

cancer fight against cancer Global fight against cancer IMF International Myeloma Foundation Leif Bergsage Mayo Clinic Myeloma OncoDaily Oncology Rochester Thalidomide Vincent Rajkumar Yelak Biru
Special Coverage
Oncolibrary
Jul 5, 2025, 16:18
Thyroid Cancer Cure Rate: What Patients Should Know in 2025
Blog
Jul 5, 2025, 16:17
Razelle Kurzrock: An Abundance of Riches
Insight
Jul 5, 2025, 16:06
Goutham Sunny: VISION Trial and Beyond
Societies
Jul 5, 2025, 15:57
Radiotherapy in Neuroblastoma in the Educational Lectures on Paediatric Radiation Oncology Series - SIOP
Drugs
Jul 5, 2025, 15:54
Tafasitamab-cxix (Monjuvi): What Patients Need to Know About-2025 Updates
Science
Jul 5, 2025, 15:31
Naveen Pemmaraju: Management of BPDCN in the Setting of Severe Co-Morbidities
Blog
Jul 5, 2025, 15:31
Chris Poulios: Interdisciplinary Collaboration is Critical to Achieve Optimal Patient Care!
Blog
Jul 5, 2025, 15:28
Ramy Sedhom: Recruiting Two Medical Oncologists For Our Princeton Site in New Jersey
Blog
Jul 5, 2025, 15:23
Karen Knudsen: Science is Finally Catching up to the Need in Sarcomas
Insight
Jul 5, 2025, 15:22
Yan Leyfman: AI's Role in Guiding Immunotherapy Decisions in Nasopharyngeal Carcinoma
Science
Jul 5, 2025, 15:09
David Heredia: EGFRm NSCLC to SCLC Transformation - A Therapeutic Dead Zone
Insight
Jul 5, 2025, 14:57
Highlights from the ESMO Gastrointestinal Cancers Congress 2025 by Myriam Chalabi